Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer-Reference-Cited by-同舟云学术

Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer

Published:2016 Issue:35 Volume:22 Page:7951
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

da Silva Oliveira Kelly Cristina,Thomaz Araújo Taíssa Maíra,Albuquerque Camila Inagaki,Barata Gabriela Alcantara,Gigek Carolina Oliveira,Leal Mariana Ferreira,Wisnieski Fernanda,Rodrigues Mello Junior Fernando Augusto,Khayat André Salim,de Assumpção Paulo Pimentel,Rodriguez Burbano Rommel Mário,Smith Marília Cardoso,Calcagno Danielle Queiroz

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference176 articles.

1. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype

2. LAUREN P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.

3. Gastric cancer—molecular and clinical dimensions

4. Epigenetics in cancer

5. Epigenetic mechanisms in gastric cancer

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy;Journal of Mind and Medical Sciences;2023-10-31

2. Circular RNA circ_SKA3 enhances gastric cancer development by targeting miR-520h;HISTOL HISTOPATHOL;2023

3. Treasures from trash in cancer research;Oncotarget;2022-11-17

4. Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1;Current Medical Science;2022-10

5. Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance;Experimental Hematology & Oncology;2020-09-26